Recommended Treatments for Arthritis
The core treatment approach for arthritis should include a combination of non-pharmacological interventions (exercise, weight management) and pharmacological therapies (starting with paracetamol/NSAIDs), with disease-modifying antirheumatic drugs (DMARDs) initiated early for inflammatory arthritis to prevent joint damage and disability.
Types of Arthritis and Initial Assessment
Different types of arthritis require different treatment approaches:
- Osteoarthritis (OA): Degenerative joint disease affecting cartilage
- Rheumatoid Arthritis (RA): Autoimmune inflammatory arthritis
- Juvenile Idiopathic Arthritis (JIA): Inflammatory arthritis in children
Key assessment factors:
- Number of swollen and tender joints
- ESR or CRP levels
- Rheumatoid factor and anti-CCP antibodies (for suspected RA)
- Radiographic evidence of erosions
Non-Pharmacological Treatments
Core Treatments (Strongly Recommended)
Exercise therapy:
Weight management:
Patient education:
Additional Non-Pharmacological Options
- Physical/occupational therapy 1, 4
- Local heat or cold applications 1
- Assistive devices (walking sticks, tap turners) 1, 2
- Appropriate footwear with shock-absorbing properties 1
- Bracing, joint supports, or insoles for biomechanical joint pain 1
Pharmacological Treatment
For Osteoarthritis
First-line:
Second-line (if first-line insufficient):
Additional options:
For Rheumatoid Arthritis
Early intervention:
For symptom relief:
Treatment goal:
Medication Monitoring
- NSAIDs: Monitor CBC, liver function, renal function every 6-12 months 1
- Methotrexate: Monthly hematology, liver and renal function tests every 1-2 months 8
- Watch for signs of toxicity: nausea, fatigue, dizziness, skin/eye yellowing 8
Special Considerations
Drug Interactions and Precautions
- NSAIDs may increase risk of GI bleeding, cardiovascular events, and renal impairment 6, 7
- Methotrexate interactions with NSAIDs, penicillins, probenecid may increase toxicity 8
- Avoid NSAIDs in severe renal impairment 2
Treatment Algorithm
- Initial approach: Start with non-pharmacological core treatments for all patients
- For OA: Add paracetamol/topical NSAIDs → oral NSAIDs if needed → consider adjunctive treatments
- For RA: Start DMARDs early (methotrexate first-line) + symptomatic treatment with NSAIDs/glucocorticoids
- Monitor regularly: Assess disease activity, medication efficacy, and adverse effects
Common Pitfalls to Avoid
- Delaying DMARD therapy in RA (should start within 3 months of symptom onset)
- Using NSAIDs without considering cardiovascular, GI, and renal risks
- Neglecting non-pharmacological approaches (exercise, weight management)
- Inadequate monitoring of medication side effects
- Mistaken daily use of weekly methotrexate (can be fatal) 8
By following these evidence-based recommendations and tailoring treatment to the specific type of arthritis, patients can achieve better pain control, improved function, and potentially slow disease progression.